+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PRISMMEDI PRISMMEDI

Prism Medico and Pharmacy Share Price

₹29.81 +0.4 (1.36%)
92.20% Gain from 52W Low

10 Sep, 2026 4:01 PM (IST)

Prism Medico and Pharmacy live price: ₹29.81. It opened at ₹30 vs previous close ₹29; intraday high/low: ₹30/₹29. The 50 & 200 DMA stand at ₹28.60/₹25.90.

Prism Medico and Pharmacy Performance

  • Today's Low
  • ₹29
  • Today's High
  • ₹30
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹35
  • Open Price₹30
  • Previous Close₹29
  • Volume4,501
  • 50 DMA₹28.60
  • 100 DMA₹27.90
  • 200 DMA₹25.90

Prism Medico and Pharmacy Chart

Investment Returns

  • Over 1 Month + 9.84%
  • Over 3 Month + 4.6%
  • Over 6 Month + 32.61%
  • Over 1 Year + 81.22%

Smart Investing Starts Here Start SIP with Prism Medico and Pharmacy for Steady Growth!

Invest Now

Prism Medico and Pharmacy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -101.7
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 40
  • P/B Ratio
  • 1.8
  • Average True Range
  • 1.9
  • EPS
  • -0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.3
  • RSI
  • 55.58
  • MFI
  • 53.38

Latest Stock News Updates

Prism Medico and Pharmacy Ltd - 512217 - Reg. 34 (1) Annual Report.

Dear Sir/Madam, Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Report of the company for the Financial Year 2025-2026. You are requested to kindly take the same on record and oblige. Thanking You.

Prism Medico and Pharmacy Ltd - 512217 - Annual Report For The Financial Year 2025-2026.

Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Annual Report of the company for the financial year ended on March 31, 2026. You are required to kindly take the same on record and oblige. Thanking you.

Prism Medico and Pharmacy Ltd - 512217 - Annual Report For The Financial Year 2025-2026.

Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Annual Report of the company for the financial year ended on March 31, 2026. You are required to kindly take the same on record and oblige. Thanking you.

Prism Medico and Pharmacy Financials

Prism Medico and Pharmacy Technicals

EMA & SMA

Current Price
₹29.81
+ 0.4 (1.36%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹29.10
  • 50 Day
  • ₹28.60
  • 100 Day
  • ₹27.90
  • 200 Day
  • ₹25.90

Resistance and Support

29.6 Pivot Speed
  • R3 31.10
  • R2 30.60
  • R1 30.20
  • S1 29.20
  • S2 28.60
  • S3 28.20

Prism Medico and Pharmacy Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-24 Others
2026-08-12 Quarterly Results
2026-05-28 Audited Results
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results

Prism Medico and Pharmacy Shareholding Pattern

70.02%
29.98%
0%

About Prism Medico and Pharmacy

Prism Medico and Pharmacy is an Indian public-listed company engaged in trading, financial investments, and basic chemical and agricultural product View More
  • NSE Symbol
  • PRISMMEDI
  • BSE Symbol
  • 512217
  • ISIN
  • INE730E01016

Similar Stocks to Prism Medico and Pharmacy

Prism Medico and Pharmacy FAQs

Prism Medico and Pharmacy share price is ₹29 As on 10 September, 2026 | 23:16

The Market Cap of Prism Medico and Pharmacy is ₹40.4 Cr As on 10 September, 2026 | 23:16

The P/E ratio of Prism Medico and Pharmacy is -101.7 As on 10 September, 2026 | 23:16

The PB ratio of Prism Medico and Pharmacy is 1.8 As on 10 September, 2026 | 23:16

The 52 week High & Low of Prism Medico and Pharmacy is ₹34.5/₹15.5 respectively As on 10 September, 2026 | 23:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23